Table 1.
Women distribution according to cytology and age and histology results
| |
Squamous lesions |
Glandular lesions |
|||||
|---|---|---|---|---|---|---|---|
| |
(Histology) |
(Histology) |
|||||
|
TOTAL |
CIN1 |
CIN2 |
CIN3 |
CC |
AIS |
CC |
|
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |
|
Cytology |
|
|
|
|
|
|
|
| Normal |
37 (11) |
19 (23) |
6 (10) |
12 (7) |
0 |
0 |
0 |
|
Squamous lesions |
|
|
|
|
|
|
|
| ASC-US/LSIL |
46 (14) |
26 (32) |
8 (13) |
12 (8) |
0 |
0 |
0 |
| ASC-H/HSIL |
169 (52) |
22 (27) |
37 (61) |
103 (65) |
3 (100) |
3 (24) |
1 (10) |
|
Glandular lesions |
|
|
|
|
|
|
|
| AGC |
65 (20) |
15 (18) |
9 (15) |
27 (17) |
0 |
8 (60) |
6 (60) |
| AGC-HSIL |
6 (2) |
0 |
1 (1) |
4 (2) |
0 |
1 (8) |
0 |
| AIS |
5 (1) |
0 |
0 |
1 (1) |
0 |
1 (8) |
3 (30) |
|
AGE (years) |
|
|
|
|
|
|
|
| ≤ 19 |
12 (4) |
5 (6) |
3 (5) |
3 (2) |
1 (33) |
0 |
0 |
| 20-29 |
107 (32) |
35 (43) |
22 (36) |
48 (31) |
0 |
1 (8) |
1 (10) |
| 30-39 |
87 (27) |
22 (26) |
16 (27) |
42 (26) |
1 (33) |
5 (38) |
1 (10) |
| 40-49 |
74 (22) |
13 (16) |
15 (24) |
40 (25) |
0 |
4 (30) |
2 (20) |
| 50-59 |
36 (11) |
7 (9) |
3 (5) |
19 (12) |
0 |
2 (16) |
5 (50) |
| ≥ 60 |
12 (4) |
0 |
2 (3) |
7 (4) |
1 (33) |
1 (8) |
1 (10) |
| TOTAL | 328 (100) | 82 (100) | 61 (100) | 159 (100) | 3 (100) | 13 (100) | 10 (100) |
CIN: cervical intraepithelial neoplasia, CC invasive cervical cancer, AIS: in situ adenocarcinoma, ASC-US/LSIL: atypical squamous cells of undetermined significance/ low-grade squamous intraepithelial lesion, ASC-H/HSIL: atypical squamous cells, cannot exclude high-grade intraepithelial lesion/high-grade squamous intraepithelial lesion, AGC = atypical glandular cells, AGC-HSIL = atypical glandular cells associated with high-grade squamous intraepithelial lesion, AIS = in situ adenocarcinoma.